Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

GH

Guardant Health Inc

Mar 18 • 04:00PM ET

43.85

Dollar change +0.95
Percentage change 2.21	%

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN QGEN EXAS FLGT BIO SRPT MYGN NTRA CDNA TXG

| Held by: VTI IWM VB VXF VBK ARKG IWO SCHA VTWO CGGR

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.56	Insider Own	4.39%	Shs Outstand	123.99M	Perf Week	2.86%
Market Cap	5.41B	Forward P/E	-	EPS next Y	-2.45	Insider Trans	-0.39%	Shs Float	118.00M	Perf Month	-8.87%
Income	-436.37M	PEG	-	EPS next Q	-0.75	Inst Own	96.28%	Short Float	6.69%	Perf Quarter	25.50%
Sales	739.02M	P/S	7.32	EPS this Y	19.11%	Inst Trans	-5.58%	Short Ratio	3.33	Perf Half Y	63.68%
Book/sh	-1.13	P/B	-	EPS next Y	14.92%	ROA	-26.67%	Short Interest	7.90M	Perf Year	130.79%
Cash/sh	6.81	P/C	6.44	EPS next 5Y	17.42%	ROE	-4584.47%	52W Range	15.81 - 50.89	Perf YTD	43.54%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-33.61%	ROI	-37.39%	52W High	-13.83%	Beta	1.46
Dividend TTM	-	Quick Ratio	4.36	Sales past 5Y	28.17%	Gross Margin	60.79%	52W Low	177.36%	ATR (14)	3.08
Dividend Ex-Date	-	Current Ratio	4.68	EPS Y/Y TTM	16.91%	Oper. Margin	-60.02%	RSI (14)	53.14	Volatility	8.50% 7.51%
Employees	2021	Debt/Eq	-	Sales Y/Y TTM	31.04%	Profit Margin	-59.05%	Recom	1.48	Target Price	55.33
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	43.17%	Payout	-	Rel Volume	0.63	Prev Close	42.90
Sales Surprise	5.04%	EPS Surprise	-17.69%	Sales Q/Q	30.16%	Earnings	Feb 20 AMC	Avg Volume	2.37M	Price	43.85
SMA20	3.65%	SMA50	1.98%	SMA200	36.78%	Trades		Volume	1,496,026	Change	2.21%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-23-25	Initiated	Barclays	Overweight	$60
Jun-28-24	Upgrade	Guggenheim	Neutral → Buy	$36
Jun-03-24	Resumed	Jefferies	Buy	$32
Apr-24-24	Resumed	Craig Hallum	Buy	$28
Dec-14-23	Initiated	Guggenheim	Neutral
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Nov-13-23	Upgrade	Raymond James	Mkt Perform → Outperform	$27
Sep-28-23	Initiated	Bernstein	Outperform	$34
Sep-27-23	Upgrade	Piper Sandler	Neutral → Overweight	$40
Jul-05-23	Resumed	JP Morgan	Overweight	$65
May-26-23	Upgrade	Citigroup	Neutral → Buy	$28 → $40
May-05-23	Initiated	UBS	Buy	$40
Mar-09-23	Downgrade	Citigroup	Buy → Neutral	$60 → $33
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$36
Nov-01-22	Downgrade	Piper Sandler	Overweight → Neutral	$65 → $50
Oct-19-22	Initiated	Craig Hallum	Buy	$88
Oct-06-22	Initiated	Stephens	Overweight	$99
Aug-25-22	Initiated	Credit Suisse	Outperform	$80
Jun-03-22	Initiated	Piper Sandler	Overweight	$65
Apr-28-22	Resumed	BTIG Research	Buy	$135 → $115

Show Previous Ratings

Mar-11-25 06:46PM	Analyst Report: Guardant Health, Inc. (Morningstar Research) +18.95%
07:00AM	Guardant Health Receives ADLT Status From CMS for Shield Blood Test (Business Wire)
Mar-10-25 07:12PM	Analyst Report: Guardant Health, Inc. (Morningstar Research) -8.85%
Mar-05-25 08:05AM	Guardant Health Joins Forces With Dak Prescott's Faith Fight Finish Foundation and Feist-Weiller Cancer Center's Partners in Wellness to Boost Colon Cancer Screening in Underserved Communities (Business Wire)
Mar-03-25 02:49PM	Guardant Healths (NASDAQ:GH) Q4: Beats On Revenue (StockStory)
05:05PM	Loading…
Feb-28-25 05:05PM	Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Feb-27-25 08:05AM	New Guardant Health/Harris Poll Survey Highlights Patient Fear and Anxiety as Major Barriers to Colorectal Cancer Screening, but Blood Test Option Offers Hope for Change (Business Wire)
Feb-26-25 11:53AM	Guardant Health (GH): Among the Best Performing Mid Cap Stocks to Buy According to Analysts (Insider Monkey) +7.04%
Feb-25-25 09:40AM	Is Guardant Health (GH) Outperforming Other Medical Stocks This Year? (Zacks)
Feb-24-25 06:00AM	Guardant accuses Natera of poaching employees, stealing trade secrets (MedTech Dive)
Feb-22-25 09:20AM	Guardant Health price target raised to $56 from $42 at TD Cowen (TipRanks)
Feb-21-25 04:58PM	These Biotech Stocks Aren't Profitable But Still Make Elite IBD 50 (Investor's Business Daily) -9.56%
01:33PM	What's Going On With Cancer Diagnostic Firm Guardant Health On Friday? (Benzinga)
10:13AM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
02:15AM	Guardant Health Inc (GH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
06:30PM	Loading…
Feb-20-25 06:30PM	Guardant Health (GH) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
05:40PM	Guardant Health (GH) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:54PM	Guardant Health: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Guardant Health Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook (Business Wire)
Feb-19-25 02:43PM	Why Guardant Health, Inc. (GH) is the Best Performing Healthcare Stock So Far in 2025 (Insider Monkey)
Feb-17-25 09:16AM	Exploring Analyst Estimates for Guardant Health (GH) Q4 Earnings, Beyond Revenue and EPS (Zacks)
Feb-13-25 10:00AM	Guardant Health (GH) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Feb-11-25 09:55AM	Here's Why Guardant Health (GH) Is a Great 'Buy the Bottom' Stock Now (Zacks)
Feb-10-25 07:00AM	Guardant Health to Participate in Upcoming Investor Conferences (Business Wire)
Feb-07-25 06:30AM	Guardant Health Announces Debt Exchange Transactions (Business Wire)
Feb-06-25 09:40AM	Are Medical Stocks Lagging Guardant Health (GH) This Year? (Zacks)
Feb-02-25 04:27PM	Why Guardant Health, Inc. (GH) Is Among the Best Booming Stocks to Invest in Now? (Insider Monkey)
Jan-30-25 04:05PM	Guardant Health to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025 (Business Wire) -5.93%
08:05AM	Guardant Healths Shield Test Selected by Abu Dhabi Department of Health for Blood-Based Colorectal Cancer Screening Program (Business Wire)
Jan-26-25 03:22AM	Why Guardant Health (GH) Is Skyrocketing Now (Insider Monkey)
08:05AM	Loading…
Jan-23-25 08:05AM	Guardant Health to Present Data at ASCO GI Demonstrating the Value of Its Precision Oncology Tools for Cancer Detection, Treatment Decisions and Therapy Development (Business Wire)
Jan-22-25 12:04PM	Why Guardant Health, Inc. (GH) Soared At The Start Of The Trading Week (Insider Monkey)
09:00AM	Oncology's Best Minds Set to Meet at Upcoming 2025 ASCO Gastrointestinal Cancers Symposium (PR Newswire)
Jan-21-25 06:49PM	Analyst Report: Guardant Health, Inc. (Morningstar Research) +23.10%
04:03PM	Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone (Investor's Business Daily)
02:15PM	Guardant Health Gains Medicare Coverage For Colorectal Cancer Monitoring Test (Benzinga)
08:05AM	Guardant Health Receives Medicare Coverage for Guardant Reveal on Smart Liquid Biopsy Platform for Surveillance Testing in Colorectal Cancer Patients (Business Wire)
Jan-20-25 12:07PM	Guardant Health, Inc. (GH) Partners with ConcertAI to Launch Advanced Real-World Data Solution for Enhanced Cancer Treatment and Clinical Trials (Insider Monkey)
Jan-16-25 04:05PM	Exact Sciences Stock Drops 11% Over Four Days. 'What Is Going On?' (Investor's Business Daily)
08:05AM	Guardant Health, ConcertAI Collaborate to Form First Data-As-A-Service That Integrates Clinical and Tumor Profiling Data to Accelerate Cancer Therapy Research and Development (Business Wire)
Jan-14-25 03:56PM	Viz.ai to Collaborate With Guardant Health to Improve Lung Cancer Detection, Diagnosis, and Treatment (Business Wire)
07:59AM	JP Morgan 2025: Guardant reports $737m in preliminary full-year revenue (Medical Device Network)
Jan-13-25 07:00AM	Guardant Health Announces Preliminary Fourth Quarter and Full Year 2024 Results (Business Wire)
Jan-07-25 08:03AM	Guardant Health Shield Platform Selected for Inclusion in National Cancer Institutes Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer Detection (Business Wire)
04:14AM	Guardant Health (GH) Soars 6.3%: Is Further Upside Left in the Stock? (Zacks)
Jan-02-25 04:05PM	Guardant Health to Participate in the 43rd Annual J.P. Morgan Healthcare Conference (Business Wire) +6.26%
Dec-20-24 08:05AM	Meaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care (Business Wire)
Dec-19-24 06:00AM	COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics (Business Wire)
Dec-18-24 08:05AM	Guardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer (Business Wire) -7.12%
Dec-09-24 08:05AM	Guardant Health to Share New Research Demonstrating Value of Liquid Biopsy Tests, Real-world Data and AI Analytics in Tailoring Treatment Approaches for Breast Cancer at 2024 San Antonio Breast Cancer Symposium (Business Wire)
Dec-02-24 05:00AM	Guardant awarded nearly $293M in false ad trial against Natera (MedTech Dive)
Nov-25-24 05:09PM	Federal Court Jury Issues Unanimous Verdict that Natera Engaged in False Advertising and Unfair Competition in Deliberate Attempt to Damage Guardant Health's Colorectal Cancer Test, Guardant Reveal (PR Newswire) +8.42%
Nov-23-24 10:29AM	Guardant Health, Inc. (GH): Among the Most Promising Cancer Stocks According to Hedge Funds (Insider Monkey)
Nov-22-24 02:21PM	Guardant Health (GH) Set To Dominate The Growing Liquid Biopsy Market (Insider Monkey) +5.39%
Nov-20-24 02:44PM	Guardant Health Stock Sees RS Rating Jump To 83 (Investor's Business Daily)
Nov-13-24 05:05PM	Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +6.32%
Nov-12-24 11:55AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Nov-07-24 05:37PM	Why Guardant Health Stock Blasted 13% Higher on Thursday (Motley Fool) +13.05%
04:05PM	Guardant Health Pops 13% On An 'Impressive' Beat Following Exact Sciences' Flop (Investor's Business Daily)
10:05AM	Guardant Health Rockets 25% On An 'Impressive' Beat Following Exact Sciences' Flop (Investor's Business Daily)
09:37AM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
04:01AM	Guardant Health Inc (GH) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
Nov-06-24 08:00PM	Guardant Health (GH) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks) +7.53%
06:40PM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
06:15PM	Guardant Health (GH) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
05:13PM	Guardant Health: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Guardant Health Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance (Business Wire)
Nov-05-24 09:15AM	Unveiling Guardant Health (GH) Q3 Outlook: Wall Street Estimates for Key Metrics (Zacks)
Nov-01-24 07:00AM	Guardant Health to Participate in Upcoming Investor Conferences (Business Wire) +5.12%
Oct-30-24 06:52PM	Why Guardant Health Stock Was the Picture of Health Today (Motley Fool) +5.87% -5.16%
10:01AM	Will Guardant Health (GH) Report Negative Earnings Next Week? What You Should Know (Zacks)
09:30AM	Guardant Health Named to TIME's List of the Best Inventions of 2024 (Business Wire)
Oct-28-24 08:05AM	Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Colorectal Cancer Screening at ACG 2024 (Business Wire) +8.24%
Oct-24-24 05:05PM	Roberto A. Mignone Joins Guardant Health Board of Directors (Business Wire)
Oct-15-24 04:05PM	Guardant Health to Report Third Quarter 2024 Financial Results on November 6, 2024 (Business Wire)
Oct-07-24 09:10PM	Deep Track Capital, LP Increases Stake in Guardant Health Inc (GuruFocus.com)
Oct-03-24 06:42PM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
Sep-18-24 08:05AM	GOZILA Study Published in Nature Medicine Shows Patients With Advanced Cancer Who Receive Liquid Biopsy-Guided Treatment Using Guardant360 CDx Survive Twice as Long (Business Wire)
Sep-17-24 07:00AM	The Battle Brewing Over Blood Tests for Cancer (The Wall Street Journal)
Sep-13-24 02:00AM	Guardant Health to Share Data at ESMO 2024 Further Demonstrating Strong Performance of Its Precision Oncology Technology in Multiple Advanced Tumor Types (Business Wire)
Sep-10-24 08:00AM	Guardant Health and Policlinico Gemelli Announce Partnership to Establish A Dedicated In-House Liquid Biopsy Testing Service in Italy (Business Wire) +8.58%
Aug-27-24 04:05PM	Guardant Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference (Business Wire)
Aug-26-24 12:56PM	Midday movers: PDD Holdings, NVIDIA fall; Xpeng gains (Investing.com) -7.86%
10:40AM	Why Guardant Health Stock Just Crashed 10% (Motley Fool)
Aug-23-24 10:45AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
06:00AM	Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG) (News Direct)
Aug-22-24 05:00PM	Guardant Health to Ring the Nasdaq Opening Bell on August 28 to Celebrate the Launch of Shield Blood Test for Colorectal Cancer Screening (Business Wire)
Aug-12-24 11:45AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool) +5.07%
Aug-09-24 04:48PM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
Aug-08-24 04:05PM	Guardant Health to Participate in Upcoming Investor Conferences (Business Wire) -10.87%
09:35AM	Guardant Health (GH) Recently Broke Out Above the 20-Day Moving Average (Zacks)
Aug-07-24 07:30PM	Guardant Health (GH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks) +5.60%
06:50PM	Guardant Health (GH) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
05:49PM	Guardant Health: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Guardant Health Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance (Business Wire)
08:05AM	Guardant Health COSMOS Study Published in Clinical Cancer Research Validates Utility of Guardant Reveal Liquid Biopsy Test for Predicting Recurrence in Colorectal Cancer (Business Wire)
Aug-06-24 09:15AM	What Analyst Projections for Key Metrics Reveal About Guardant Health (GH) Q2 Earnings (Zacks) +5.27%
Aug-01-24 04:02PM	Why Exact Sciences, Up 27%, Is 'Coiled To Snap Back' After Quarterly Beat (Investor's Business Daily) -5.04%
08:30AM	Guardant Healths FDA-approved Shield Blood Test Now Commercially Available in U.S. as a Primary Screening Option for Colorectal Cancer (Business Wire)
08:00AM	Guardant Health Outcomes Model Confirms the Public Health Importance of Enhanced Colorectal Cancer Screening Outcomes with High Adherence Strategies (Business Wire)

Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in December 2011 and is headquartered in Palo Alto, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kalia Kumud	Officer	Mar 17 '25	Proposed Sale	43.16	3,500	151,060		Mar 17 04:24 PM
Joyce Meghan V.	Director	Mar 04 '25	Option Exercise	0.00	67	0	7,714	Mar 05 04:48 PM
Joyce Meghan V.	Director	Mar 03 '25	Sale	42.71	100	4,271	7,647	Mar 05 04:48 PM
Saia John G.	Chief Legal Officer	Mar 01 '25	Option Exercise	0.00	5,949	0	40,650	Mar 04 06:16 PM
Monroe Terilyn J.	Chief People Officer	Mar 01 '25	Option Exercise	0.00	14,894	0	26,822	Mar 04 06:15 PM
Kalia Kumud	Chief Information Officer	Mar 01 '25	Option Exercise	0.00	4,406	0	24,401	Mar 04 06:13 PM
Freeman Chris	Chief Commercial Officer	Mar 01 '25	Option Exercise	0.00	5,686	0	40,355	Mar 04 06:11 PM
EAGLE CRAIG	Chief Medical Officer	Mar 01 '25	Option Exercise	0.00	5,686	0	31,642	Mar 04 06:10 PM
Chudova Darya	Chief Technology Officer	Mar 01 '25	Option Exercise	0.00	6,001	0	76,065	Mar 04 06:08 PM
Bell Michael Brian	Chief Financial Officer	Mar 01 '25	Option Exercise	0.00	7,108	0	40,285	Mar 04 06:07 PM
Krognes Steve E.	Director	Feb 28 '25	Option Exercise	0.00	154	0	10,528	Mar 04 06:05 PM
Joyce Meghan V.	Director	Mar 03 '25	Proposed Sale	42.71	100	4,271		Mar 03 04:11 PM
Tariq Musa	Director	Feb 20 '25	Sale	48.33	116	5,606	3,078	Feb 21 05:54 PM
Tariq Musa	Director	Feb 20 '25	Proposed Sale	48.33	116	5,606		Feb 20 04:04 PM
Tariq Musa	Director	Feb 15 '25	Option Exercise	0.00	250	0	3,194	Feb 18 04:58 PM
POTTER MYRTLE S	Director	Feb 15 '25	Option Exercise	0.00	68	0	13,858	Feb 18 04:57 PM
Joyce Meghan V.	Director	Feb 04 '25	Option Exercise	0.00	66	0	7,747	Feb 05 04:33 PM
Chudova Darya	Chief Technology Officer	Feb 01 '25	Option Exercise	0.00	21,863	0	78,416	Feb 04 05:14 PM
Bell Michael Brian	Chief Financial Officer	Feb 01 '25	Option Exercise	0.00	6,617	0	35,538	Feb 04 05:13 PM
Krognes Steve E.	Director	Jan 31 '25	Option Exercise	0.00	154	0	10,374	Feb 04 05:11 PM
Tariq Musa	Director	Jan 17 '25	Sale	37.58	116	4,359	2,944	Jan 21 05:11 PM
Tariq Musa	Director	Jan 17 '25	Proposed Sale	37.58	116	4,359		Jan 17 04:08 PM
Tariq Musa	Director	Jan 15 '25	Option Exercise	0.00	250	0	3,060	Jan 16 05:07 PM
POTTER MYRTLE S	Director	Jan 15 '25	Option Exercise	0.00	68	0	13,790	Jan 16 05:05 PM
Monroe Terilyn J.	Chief People Officer	Jan 15 '25	Option Exercise	0.00	17,378	0	18,348	Jan 16 05:04 PM
Bell Michael Brian	Chief Financial Officer	Jan 15 '25	Option Exercise	0.00	3,309	0	30,226	Jan 16 05:03 PM
Joyce Meghan V.	Director	Jan 04 '25	Option Exercise	0.00	66	0	7,681	Jan 06 06:25 PM
Saia John G.	Chief Legal Officer	Jan 01 '25	Option Exercise	0.00	2,641	0	36,201	Jan 03 06:02 PM
Kalia Kumud	Chief Information Officer	Jan 01 '25	Option Exercise	0.00	2,690	0	21,098	Jan 03 06:00 PM
Freeman Chris	Chief Commercial Officer	Jan 01 '25	Option Exercise	0.00	3,595	0	35,852	Jan 03 05:59 PM
EAGLE CRAIG	Chief Medical Officer	Jan 01 '25	Option Exercise	0.00	3,381	0	27,343	Jan 03 05:58 PM
Chudova Darya	Chief Technology Officer	Jan 01 '25	Option Exercise	0.00	3,006	0	57,786	Jan 03 05:56 PM
Bell Michael Brian	Chief Financial Officer	Jan 01 '25	Option Exercise	0.00	2,084	0	27,772	Jan 03 05:55 PM
Talasaz AmirAli	Co-Chief Executive Officer	Dec 31 '24	Option Exercise	0.00	11,462	0	2,215,894	Jan 03 05:54 PM
Talasaz AmirAli	Co-Chief Executive Officer	Jan 01 '25	Option Exercise	0.00	94,555	0	2,304,640	Jan 03 05:54 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Dec 31 '24	Option Exercise	0.00	11,462	0	2,315,728	Jan 03 05:52 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Jan 01 '25	Option Exercise	0.00	94,555	0	2,404,474	Jan 03 05:52 PM
Krognes Steve E.	Director	Dec 31 '24	Option Exercise	0.00	155	0	10,220	Jan 02 04:52 PM
Tariq Musa	Director	Dec 18 '24	Sale	34.85	116	4,043	2,810	Dec 19 06:29 PM
Tariq Musa	Director	Dec 18 '24	Proposed Sale	34.85	116	4,043		Dec 18 04:38 PM
Saia John G.	Chief Legal Officer	Dec 15 '24	Option Exercise	0.00	1,020	0	34,095	Dec 16 06:28 PM
POTTER MYRTLE S	Director	Dec 15 '24	Option Exercise	0.00	69	0	13,722	Dec 16 06:26 PM
Kalia Kumud	Chief Information Officer	Dec 15 '24	Option Exercise	0.00	637	0	18,731	Dec 16 06:25 PM
Freeman Chris	Chief Commercial Officer	Dec 15 '24	Option Exercise	0.00	1,402	0	32,854	Dec 16 06:16 PM
EAGLE CRAIG	Chief Medical Officer	Dec 15 '24	Option Exercise	0.00	1,402	0	24,673	Dec 16 06:14 PM
Bell Michael Brian	Chief Financial Officer	Dec 15 '24	Option Exercise	0.00	3,272	0	27,347	Dec 16 06:12 PM
Tariq Musa	Director	Dec 15 '24	Option Exercise	0.00	250	0	2,926	Dec 16 06:11 PM
Tariq Musa	Director	Dec 13 '24	Sale	35.00	2,320	81,200	2,676	Dec 16 06:11 PM
Tariq Musa	Director	Dec 13 '24	Proposed Sale	35.00	2,320	81,200		Dec 13 04:30 PM
Joyce Meghan V.	Director	Dec 04 '24	Option Exercise	0.00	67	0	7,615	Dec 05 06:42 PM
Joyce Meghan V.	Director	Dec 02 '24	Sale	35.90	100	3,590	7,548	Dec 03 07:00 PM
Saia John G.	Chief Legal Officer	Dec 01 '24	Option Exercise	0.00	263	0	33,213	Dec 02 07:27 PM
Kalia Kumud	Chief Information Officer	Dec 01 '24	Option Exercise	0.00	710	0	18,454	Dec 02 07:25 PM
Chudova Darya	Chief Technology Officer	Dec 01 '24	Option Exercise	0.00	316	0	54,941	Dec 02 07:21 PM
Krognes Steve E.	Director	Nov 30 '24	Option Exercise	0.00	154	0	10,065	Dec 02 07:20 PM
Joyce Meghan V.	Director	Dec 02 '24	Proposed Sale	35.90	100	3,590		Dec 02 04:03 PM
Kalia Kumud	Chief Information Officer	Nov 18 '24	Sale	29.25	7,000	204,722	17,744	Nov 19 05:13 PM
Tariq Musa	Director	Nov 15 '24	Option Exercise	0.00	250	0	4,996	Nov 18 07:34 PM
POTTER MYRTLE S	Director	Nov 15 '24	Option Exercise	0.00	68	0	13,653	Nov 18 07:32 PM
Kalia Kumud	Officer	Nov 18 '24	Proposed Sale	29.25	7,000	204,722		Nov 18 04:04 PM
Joyce Meghan V.	Director	Nov 13 '24	Sale	29.90	2,896	86,595	7,648	Nov 14 05:59 PM
CLARK IAN T	Director	Nov 12 '24	Option Exercise	4.18	1,076	4,498	16,753	Nov 14 05:58 PM
CLARK IAN T	Director	Nov 12 '24	Sale	29.45	8,318	244,930	8,435	Nov 14 05:58 PM
Joyce Meghan V.	Director	Nov 13 '24	Proposed Sale	29.90	2,896	86,595		Nov 13 04:27 PM
CLARK IAN T	Director	Nov 12 '24	Proposed Sale	29.45	8,318	244,930		Nov 12 04:24 PM
Joyce Meghan V.	Director	Nov 04 '24	Option Exercise	0.00	66	0	10,544	Nov 05 04:37 PM
Chudova Darya	Chief Technology Officer	Nov 04 '24	Option Exercise	0.00	9,756	0	59,570	Nov 05 04:36 PM
Krognes Steve E.	Director	Oct 31 '24	Option Exercise	0.00	154	0	9,911	Nov 04 05:28 PM
Tariq Musa	Director	Oct 15 '24	Option Exercise	0.00	250	0	4,746	Oct 16 06:33 PM
POTTER MYRTLE S	Director	Oct 15 '24	Option Exercise	0.00	69	0	13,585	Oct 16 06:32 PM
Joyce Meghan V.	Director	Oct 04 '24	Option Exercise	0.00	66	0	10,478	Oct 07 05:22 PM
Saia John G.	Chief Legal Officer	Oct 01 '24	Option Exercise	0.00	7,543	0	36,774	Oct 02 04:56 PM
Kalia Kumud	Chief Information Officer	Oct 01 '24	Option Exercise	0.00	5,877	0	27,724	Oct 02 04:54 PM
Freeman Chris	Chief Commercial Officer	Oct 01 '24	Option Exercise	0.00	8,498	0	35,072	Oct 02 04:53 PM
EAGLE CRAIG	Chief Medical Officer	Oct 01 '24	Option Exercise	0.00	8,284	0	27,471	Oct 02 04:51 PM
Chudova Darya	Chief Technology Officer	Oct 01 '24	Option Exercise	0.00	7,908	0	53,823	Oct 02 04:50 PM
Bell Michael Brian	Chief Financial Officer	Oct 01 '24	Option Exercise	0.00	8,211	0	28,237	Oct 02 04:48 PM
Talasaz AmirAli	Co-Chief Executive Officer	Sep 30 '24	Option Exercise	0.00	11,461	0	2,210,241	Oct 01 05:59 PM
Krognes Steve E.	Director	Sep 30 '24	Option Exercise	0.00	154	0	9,757	Oct 01 05:58 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Sep 30 '24	Option Exercise	0.00	11,461	0	2,310,075	Oct 01 05:51 PM
Tariq Musa	Director	Sep 15 '24	Option Exercise	0.00	249	0	4,496	Sep 16 05:34 PM
Saia John G.	Chief Legal Officer	Sep 15 '24	Option Exercise	0.00	1,019	0	29,748	Sep 16 05:33 PM
POTTER MYRTLE S	Director	Sep 15 '24	Option Exercise	0.00	68	0	13,516	Sep 16 05:32 PM
Kalia Kumud	Chief Information Officer	Sep 15 '24	Option Exercise	0.00	638	0	22,171	Sep 16 05:31 PM
Freeman Chris	Chief Commercial Officer	Sep 15 '24	Option Exercise	0.00	1,402	0	27,171	Sep 16 05:29 PM
EAGLE CRAIG	Chief Medical Officer	Sep 15 '24	Option Exercise	0.00	1,402	0	19,898	Sep 16 05:28 PM
Bell Michael Brian	Chief Financial Officer	Sep 15 '24	Option Exercise	0.00	3,272	0	21,685	Sep 16 05:27 PM
Kalia Kumud	Chief Information Officer	Sep 09 '24	Option Exercise	0.00	6,545	0	24,851	Sep 10 05:00 PM
Chudova Darya	Chief Technology Officer	Sep 09 '24	Option Exercise	0.00	2,909	0	47,175	Sep 10 04:58 PM
Joyce Meghan V.	Director	Sep 04 '24	Option Exercise	0.00	67	0	10,412	Sep 05 04:52 PM
Saia John G.	Chief Legal Officer	Sep 01 '24	Option Exercise	0.00	263	0	29,306	Sep 03 04:47 PM
Kalia Kumud	Chief Information Officer	Sep 01 '24	Option Exercise	0.00	710	0	18,666	Sep 03 04:46 PM
Chudova Darya	Chief Technology Officer	Sep 01 '24	Option Exercise	0.00	316	0	44,379	Sep 03 04:45 PM
Krognes Steve E.	Director	Aug 31 '24	Option Exercise	0.00	155	0	9,603	Sep 03 04:43 PM
Tariq Musa	Director	Aug 15 '24	Option Exercise	0.00	250	0	4,247	Aug 19 05:18 PM
POTTER MYRTLE S	Director	Aug 15 '24	Option Exercise	0.00	68	0	13,448	Aug 19 05:17 PM
Joyce Meghan V.	Director	Aug 04 '24	Option Exercise	0.00	66	0	10,345	Aug 05 06:10 PM
Krognes Steve E.	Director	Jul 31 '24	Option Exercise	0.00	154	0	9,448	Aug 01 06:46 PM
Tariq Musa	Director	Jul 15 '24	Option Exercise	0.00	250	0	3,997	Jul 16 04:35 PM
POTTER MYRTLE S	Director	Jul 15 '24	Option Exercise	0.00	69	0	13,380	Jul 16 04:33 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GH

Guardant Health Inc

Upgrade your FINVIZ experience